News
'GOP Senators Tell DEA To Reject Marijuana Rescheduling, Arguing It Would Violate International Treaties' - Marijuana Moment
27 Mar 24
Macro Economic Events, News, Politics, Legal, Economics, General
FSD Pharma Signs Agreement With iNGENu CRO To Conduct A Clinical Study To Assess The Safety And Pharmacokinetics Of Multiple Ascending Doses Of Lucid-21-302 In Healthy Adults
27 Mar 24
Biotech, News, General
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
16 Mar 24
Biotech, Cannabis, Psychedelics, Financing, Legal, Management, Global
'DEA Officials Reportedly At Odds With Biden Admin Over Marijuana Rescheduling Push' - Marijuana Moment
11 Mar 24
Macro Economic Events, News, Politics, Economics, General
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
4 Mar 24
Cannabis, Psychedelics, Financing, FDA, Legal, Management, Global
Too Drunk? This Beverage Could Sober You Up Quickly
26 Feb 24
Biotech, Cannabis, Psychedelics
FSD Pharma Signs Agreement With Ingenu CRO To Conduct A Clinical Trial To Determine The Safety And Efficacy Effects Of Its Proprietary Blend Beverage "unbuzzd"
26 Feb 24
Biotech, News, General
Safety Shot Responds To FSD Pharma's Unauthorized Tagging Of Its Stock And Making False Claims In An Effort To Harm The Company And Its Shareholders
17 Jan 24
News, Legal
GBB Drink Lab. Inc Announce That A Federal Court Has Refused To Dismiss The Company's Ongoing Lawsuit Against FSD Pharma
11 Jan 24
News, Legal
Press releases
FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
27 Mar 24
News, Press Releases
FSD Pharma: A Compelling Value Proposition As UNBUZZD™ Positions To Dominate The Alcohol-Detox Functional Beverage Market
14 Mar 24
News, Press Releases
FSD Pharma's Stake In Functional Beverage, UNBUZZD™, Is A Transformational Asset…Here's Why
12 Mar 24
News, Press Releases
FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
5 Mar 24
News, Press Releases
FSD Pharma Announces Debt Settlement
28 Feb 24
News, Press Releases
FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
26 Feb 24
News, Press Releases
FSD Pharma Announces US ATM Offering
16 Feb 24
News, Press Releases
Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
6 Feb 24
News, Press Releases
FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
29 Jan 24
News, Press Releases
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
16 Jan 24
News, Press Releases
GBB Maintains Strong Position in its Ongoing Lawsuit with FSD Pharma After Court Refuses to Dismiss Case
11 Jan 24
News, Legal, Press Releases